BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10233892)

  • 1. Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
    Praticò D; Ferro D; Iuliano L; Rokach J; Conti F; Valesini G; FitzGerald GA; Violi F
    Blood; 1999 May; 93(10):3401-7. PubMed ID: 10233892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E reduces monocyte tissue factor expression in cirrhotic patients.
    Ferro D; Basili S; Praticó D; Iuliano L; FitzGerald GA; Violi F
    Blood; 1999 May; 93(9):2945-50. PubMed ID: 10216089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
    Martinuzzo ME; Forastiero RR; Kordich L; Carreras LO
    Br J Haematol; 2001 Sep; 114(4):845-51. PubMed ID: 11564073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies.
    Iuliano L; Praticò D; Ferro D; Pittoni V; Valesini G; Lawson J; FitzGerald GA; Violi F
    Blood; 1997 Nov; 90(10):3931-5. PubMed ID: 9354660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.
    Ginsberg JS; Demers C; Brill-Edwards P; Bona R; Johnston M; Wong A; Denburg JA
    Am J Med; 1995 Apr; 98(4):379-83. PubMed ID: 7709951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.
    Praticò D; Tangirala RK; Hörkkö S; Witztum JL; Palinski W; FitzGerald GA
    Blood; 2001 Jan; 97(2):459-64. PubMed ID: 11154223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of prothrombin fragment 1.2 (F 1.2) in the diagnosis of stroke in young patients with antiphospholipid antibodies.
    Ellis MH; Kesler A; Friedman Z; Drucker I; Radnai Y; Kott E
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):61-4. PubMed ID: 10775022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin E on lipid peroxidation in healthy persons.
    Meagher EA; Barry OP; Lawson JA; Rokach J; FitzGerald GA
    JAMA; 2001 Mar; 285(9):1178-82. PubMed ID: 11231747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
    Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
    Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state.
    Ferro D; Pittoni V; Quintarelli C; Basili S; Saliola M; Caroselli C; Valesini G; Violi F
    Circulation; 1997 Mar; 95(6):1425-32. PubMed ID: 9118509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of F1 + 2/TAT ratios in Japanese patients with antiphospholipid syndrome].
    Naitoh S; Ieko M; Takeda M; Atsumi T; Koike T
    Rinsho Byori; 2000 Jun; 48(6):540-6. PubMed ID: 10897673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
    Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
    Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of kakisu (persimmon vinegar) on plasma antioxidant power and urinary 8-isoprostane level].
    Mure K; Takeshita T; Morioka I; Arita M
    Nihon Eiseigaku Zasshi; 2007 Jan; 62(1):32-8. PubMed ID: 17334090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased F2 isoprostane plasma levels in patients with congestive heart failure are correlated with antioxidant status and disease severity.
    Polidori MC; Praticó D; Savino K; Rokach J; Stahl W; Mecocci P
    J Card Fail; 2004 Aug; 10(4):334-8. PubMed ID: 15309701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Vitamin E Supplementation on Plasma and Urine Levels of Isoprostane F2α in Randomized Controlled Clinical Trials: A Systematic Review and Meta-Analysis.
    Rad EY; Falahi E; Djalali M; Abbasnezhad A; Birjandi M; Saboori S
    Int J Vitam Nutr Res; 2017 Sep; 87(5-6):314-321. PubMed ID: 30010514
    [No Abstract]   [Full Text] [Related]  

  • 19. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients.
    Ceriello A; Bortolotti N; Pirisi M; Crescentini A; Tonutti L; Motz E; Russo A; Giacomello R; Stel G; Taboga C
    Diabetes Care; 1997 Oct; 20(10):1589-93. PubMed ID: 9314640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.
    Douketis JD; Crowther MA; Julian JA; Stewart K; Donovan D; Kaminska EA; Laskin CA; Ginsberg JS
    Thromb Haemost; 1999 Sep; 82(3):1028-32. PubMed ID: 10494759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.